Comparison of the Bone Regenerative Capacity of Three-Dimensional Uncalcined and Unsintered Hydroxyapatite/Poly-d/l-Lactide and Beta-Tricalcium Phosphate Used as Bone Graft Substitutes

This study compared the in vivo applicability of three-dimensional uncalcined and unsintered hydroxyapatite/poly-d/l-lactide (3D-HA/PDLLA) with beta-tricalcium phosphate (β-TCP). 3D-HA/PDLLA is a newly developed bioactive, osteoconductive, bioresorbable bone regenerative composite. We performed crit...

Full description

Bibliographic Details
Main Authors: Yunpeng Bai, Jingjing Sha, Takahiro Kanno, Kenichi Miyamoto, Katsumi Hideshima, Yumi Matsuzaki
Format: Article
Language:English
Published: Taylor & Francis Group 2021-03-01
Series:Journal of Investigative Surgery
Subjects:
Online Access:http://dx.doi.org/10.1080/08941939.2019.1616859
_version_ 1797684664934072320
author Yunpeng Bai
Jingjing Sha
Takahiro Kanno
Kenichi Miyamoto
Katsumi Hideshima
Yumi Matsuzaki
author_facet Yunpeng Bai
Jingjing Sha
Takahiro Kanno
Kenichi Miyamoto
Katsumi Hideshima
Yumi Matsuzaki
author_sort Yunpeng Bai
collection DOAJ
description This study compared the in vivo applicability of three-dimensional uncalcined and unsintered hydroxyapatite/poly-d/l-lactide (3D-HA/PDLLA) with beta-tricalcium phosphate (β-TCP). 3D-HA/PDLLA is a newly developed bioactive, osteoconductive, bioresorbable bone regenerative composite. We performed critical-defect surgery on the mandible body of rats; the defects were filled with one of two bone graft substitutes. After a 4-week follow-up period, the mandibular specimens were examined using hematoxylin and eosin (H&E) staining, immunohistochemistry (IHC) staining and micro-computed tomography (micro-CT). The H&E staining showed an increase in newly formed bone in both groups from week 1 to 4. The difference in the Runx2 IHC optical density (OD) scores of 3D-HA/PDLLA and β-TCP was not statistically significant (p > 0.05); however, the osteocalcin IHC OD scores of the groups differed significantly (p < 0.05). Micro-CT demonstrated a similar trabecular thickness, trabecular spacing, and bone volume per total volume in the two groups (p > 0.05), indicating that bone formation in the two groups was nearly the same from a macro-perspective of bone regeneration. These results demonstrated that a different bone regeneration pattern and earlier osteoblast differentiation occurred in 3D-HA/PDLLA compared with β-TCP. In conclusion, our study demonstrates that 3D-HA/PDLLA is feasible for clinical application as a new bioactive, osteoconductive/bioresorbable bone graft substitute for maxillofacial surgery.
first_indexed 2024-03-12T00:32:59Z
format Article
id doaj.art-4bf8aeffea0a4c318e9e43c40b5e2ecc
institution Directory Open Access Journal
issn 0894-1939
1521-0553
language English
last_indexed 2024-03-12T00:32:59Z
publishDate 2021-03-01
publisher Taylor & Francis Group
record_format Article
series Journal of Investigative Surgery
spelling doaj.art-4bf8aeffea0a4c318e9e43c40b5e2ecc2023-09-15T10:07:30ZengTaylor & Francis GroupJournal of Investigative Surgery0894-19391521-05532021-03-0134324325610.1080/08941939.2019.16168591616859Comparison of the Bone Regenerative Capacity of Three-Dimensional Uncalcined and Unsintered Hydroxyapatite/Poly-d/l-Lactide and Beta-Tricalcium Phosphate Used as Bone Graft SubstitutesYunpeng Bai0Jingjing Sha1Takahiro Kanno2Kenichi Miyamoto3Katsumi Hideshima4Yumi Matsuzaki5Shimane University Faculty of MedicineShimane University Faculty of MedicineShimane University Faculty of MedicineShimane University Faculty of MedicineShimane University Faculty of MedicineShimane University Faculty of MedicineThis study compared the in vivo applicability of three-dimensional uncalcined and unsintered hydroxyapatite/poly-d/l-lactide (3D-HA/PDLLA) with beta-tricalcium phosphate (β-TCP). 3D-HA/PDLLA is a newly developed bioactive, osteoconductive, bioresorbable bone regenerative composite. We performed critical-defect surgery on the mandible body of rats; the defects were filled with one of two bone graft substitutes. After a 4-week follow-up period, the mandibular specimens were examined using hematoxylin and eosin (H&E) staining, immunohistochemistry (IHC) staining and micro-computed tomography (micro-CT). The H&E staining showed an increase in newly formed bone in both groups from week 1 to 4. The difference in the Runx2 IHC optical density (OD) scores of 3D-HA/PDLLA and β-TCP was not statistically significant (p > 0.05); however, the osteocalcin IHC OD scores of the groups differed significantly (p < 0.05). Micro-CT demonstrated a similar trabecular thickness, trabecular spacing, and bone volume per total volume in the two groups (p > 0.05), indicating that bone formation in the two groups was nearly the same from a macro-perspective of bone regeneration. These results demonstrated that a different bone regeneration pattern and earlier osteoblast differentiation occurred in 3D-HA/PDLLA compared with β-TCP. In conclusion, our study demonstrates that 3D-HA/PDLLA is feasible for clinical application as a new bioactive, osteoconductive/bioresorbable bone graft substitute for maxillofacial surgery.http://dx.doi.org/10.1080/08941939.2019.16168593d-ha/pdllaβ-tcpcell differentiationendochondral ossificationintramembranous ossificationbiomaterials/biocompatibility
spellingShingle Yunpeng Bai
Jingjing Sha
Takahiro Kanno
Kenichi Miyamoto
Katsumi Hideshima
Yumi Matsuzaki
Comparison of the Bone Regenerative Capacity of Three-Dimensional Uncalcined and Unsintered Hydroxyapatite/Poly-d/l-Lactide and Beta-Tricalcium Phosphate Used as Bone Graft Substitutes
Journal of Investigative Surgery
3d-ha/pdlla
β-tcp
cell differentiation
endochondral ossification
intramembranous ossification
biomaterials/biocompatibility
title Comparison of the Bone Regenerative Capacity of Three-Dimensional Uncalcined and Unsintered Hydroxyapatite/Poly-d/l-Lactide and Beta-Tricalcium Phosphate Used as Bone Graft Substitutes
title_full Comparison of the Bone Regenerative Capacity of Three-Dimensional Uncalcined and Unsintered Hydroxyapatite/Poly-d/l-Lactide and Beta-Tricalcium Phosphate Used as Bone Graft Substitutes
title_fullStr Comparison of the Bone Regenerative Capacity of Three-Dimensional Uncalcined and Unsintered Hydroxyapatite/Poly-d/l-Lactide and Beta-Tricalcium Phosphate Used as Bone Graft Substitutes
title_full_unstemmed Comparison of the Bone Regenerative Capacity of Three-Dimensional Uncalcined and Unsintered Hydroxyapatite/Poly-d/l-Lactide and Beta-Tricalcium Phosphate Used as Bone Graft Substitutes
title_short Comparison of the Bone Regenerative Capacity of Three-Dimensional Uncalcined and Unsintered Hydroxyapatite/Poly-d/l-Lactide and Beta-Tricalcium Phosphate Used as Bone Graft Substitutes
title_sort comparison of the bone regenerative capacity of three dimensional uncalcined and unsintered hydroxyapatite poly d l lactide and beta tricalcium phosphate used as bone graft substitutes
topic 3d-ha/pdlla
β-tcp
cell differentiation
endochondral ossification
intramembranous ossification
biomaterials/biocompatibility
url http://dx.doi.org/10.1080/08941939.2019.1616859
work_keys_str_mv AT yunpengbai comparisonoftheboneregenerativecapacityofthreedimensionaluncalcinedandunsinteredhydroxyapatitepolydllactideandbetatricalciumphosphateusedasbonegraftsubstitutes
AT jingjingsha comparisonoftheboneregenerativecapacityofthreedimensionaluncalcinedandunsinteredhydroxyapatitepolydllactideandbetatricalciumphosphateusedasbonegraftsubstitutes
AT takahirokanno comparisonoftheboneregenerativecapacityofthreedimensionaluncalcinedandunsinteredhydroxyapatitepolydllactideandbetatricalciumphosphateusedasbonegraftsubstitutes
AT kenichimiyamoto comparisonoftheboneregenerativecapacityofthreedimensionaluncalcinedandunsinteredhydroxyapatitepolydllactideandbetatricalciumphosphateusedasbonegraftsubstitutes
AT katsumihideshima comparisonoftheboneregenerativecapacityofthreedimensionaluncalcinedandunsinteredhydroxyapatitepolydllactideandbetatricalciumphosphateusedasbonegraftsubstitutes
AT yumimatsuzaki comparisonoftheboneregenerativecapacityofthreedimensionaluncalcinedandunsinteredhydroxyapatitepolydllactideandbetatricalciumphosphateusedasbonegraftsubstitutes